榄忛噾鑾� 鍓暀鎺�/纭曞＋鐢熷甯�
鍦板潃锛氫笂娴峰競濂夎搐鍖烘捣鎬濊矾999鍙峰崕涓滅悊宸ュぇ瀛﹀疄楠屼簲妤�309瀹�
Email锛�weijinlian678@ecust.edu.cn
閭紪锛�200237
涓汉绠€浠�
2017骞�6鏈堟瘯涓氫簬涓浗鑽澶у鑽闄紝鑾风悊瀛﹀崥澹浣嶏紱2017骞�7鏈堣繘鍏ュ崕涓滅悊宸ュぇ瀛﹁嵂瀛﹂櫌鎵挎媴鎬濇斂宸ヤ綔锛�2020骞�1鏈堣繘鍏ュ崕涓滅悊宸ュぇ瀛﹁嵂瀛﹀崥澹悗绉戠爺娴佸姩绔欎粠浜嬪崥澹悗鐮旂┒锛屽悎浣滃甯堜负鏉庡墤鏁欐巿銆�2022骞�7鏈堝嚭绔欑暀鏍″伐浣滐紝鍔犲叆鏉庡墤鏁欐巿鍥㈤槦锛屼粠浜嬫暀瀛︾鐮斿伐浣溿€�
鐮旂┒鏂瑰悜涓昏鑷村姏浜庢姉鑲跨槫鍊欓€夋柊鑽殑鐮斿彂锛�鍩轰簬鍥㈤槦鑰佽嵂鏂扮敤涓庤€佽嵂浜屾鐮斿彂鍒涙柊绛栫暐锛屽缓绔嬩簡瀹屽鐨勪粠鈥�浣撳鎶楄偪鐦よ〃鍨嬬瓫閫�鈫�鏈哄埗纭瘉涓庡寲瀛︾敓鐗╁鐮旂┒鈫�缁撴瀯淇グ涓庢瀯鏁堝叧绯荤爺绌�鈫�鍔ㄧ墿鑽晥涓庢垚鑽€ц瘎浠�鈥�鐨勬妧鏈钩鍙颁綋绯汇€傝繎骞存潵锛屼互绗竴/閫氳浣滆€呭湪Acta Pharm. Sin. B銆�Cell Death Dis.銆�J. Med. Chem.绛夊浗鍐呭鐭ュ悕瀛︽湳鏈熷垔鍙戣〃澶氱瘒SCI鏂囩珷锛屽苟鐢宠鍙戞槑涓撳埄銆傚叆閫�2020骞翠笂娴峰競鈥�瓒呯骇鍗氬＋鍚�鈥�婵€鍔辫鍒�锛屽悓骞磋幏寰楀浗瀹惰嚜鐒剁瀛﹀熀閲戦潚骞寸瀛﹀熀閲戦」鐩€�
鏁欒偛缁忓巻
2012.09鈥�2017.06锛屼腑鍥借嵂绉戝ぇ瀛︼紝鑽闄紝鍒惰嵂宸ョ▼瀛︼紝纭曞崥锛屽甯堬細灏ゅ惎鍐�鏁欐巿锛�
2008.09鈥�2012.06锛屼腑鍥借嵂绉戝ぇ瀛︼紝鑽闄紝鍒惰嵂宸ョ▼锛屽澹€�
宸ヤ綔缁忓巻
2024.01-鑷充粖锛�鍗庝笢鐞嗗伐澶у锛岃嵂瀛﹂櫌锛屽壇鏁欐巿锛�
2022.08鈥�2023.12锛屽崕涓滅悊宸ュぇ瀛︼紝鑽闄紝璁插笀锛�
2020.01鈥�2022.07锛屽崕涓滅悊宸ュぇ瀛︼紝鑽闄紝鍗氬＋鍚庯紝鍚堜綔瀵煎笀锛氭潕鍓戞暀鎺堬紱
2017.07鈥�2019.12锛屽崕涓滅悊宸ュぇ瀛︼紝鑽闄紝鎬濇斂銆�
涓昏鐮旂┒鏂瑰悜
1. 鑰佽嵂鏂扮敤涓庤€佽嵂浜屾鐮斿彂
2. 鎶楄偪鐦ゅ垱鏂拌嵂鐗╃殑鐮斿彂涓庢柊闈舵爣鏈哄埗鐮旂┒
鑽ｈ獕鍙婄ぞ浼氬吋鑱�
1. 2024骞达紝涓浗鍥介檯澶у鐢熷垱鏂板ぇ璧�(2024)锛屼笂娴疯禌鍖洪摱濂栵紝鎸囧鏁欏笀銆�
2. 2023骞达紝鍗庝笢鐞嗗伐澶у闈掑勾浜斿洓濂栫珷锛堜釜浜猴級銆�
3. 2022骞达紝绗叓灞婁腑鍥藉浗闄�鈥�浜掕仈缃戯耿鈥�澶у鐢熷垱鏂板垱涓氬ぇ璧涳紝鍥藉绾ч摐濂栵紝鎸囧鏁欏笀銆�
4. 2022骞达紝绗崄涓夊眾鈥溾€�鎸戞垬鏉�鈥�鍏ㄥ浗澶у鐢熷垱涓氳鍒掔珵璧涳紝涓婃捣璧涘尯閾跺锛屾寚瀵兼暀甯堛€�
5. 2021骞达紝绗竷灞婁腑鍥藉浗闄�鈥�浜掕仈缃戯耿鈥�澶у鐢熷垱鏂板垱涓氬ぇ璧涳紝涓婃捣璧涘尯閾跺锛屾寚瀵兼暀甯堛€�
6. 銆婁腑鍥借嵂绉戝ぇ瀛﹀鎶ャ€嬮潚骞寸紪濮斻€�
7. 涓浗鍖昏嵂淇℃伅瀛︿細涓尰涓村簥鑽鍒嗕細鐞嗕簨銆�
娆㈣繋鏈夊織浜庤嵂鐗╁寲瀛︺€佽嵂鐞嗗浠ュ強鏂拌嵂鐮斿彂棰嗗煙鐮旂┒鐨勫鐢熷姞鍏ワ紒锛�
鎷涚敓涓撲笟锛�瀛︽湳纭曞＋(鑽100700锛夛紱涓撲笟纭曞＋锛堣嵂瀛�105500锛�
浠ｈ〃鎬ц鏂�(#鍏卞悓绗竴浣滆€咃紝*涓洪€氳浣滆€�)
1. Guangwei Cui#, Yuhang Fan#, Yue Yang, Yiwen Ma, Haiyang Deng, Pan Wang, Yuxin Zhu, Jian Li, Jinlian Wei*, Yongqiang Zhang*. Discovery of N-Trifluoromethylated Noscapines as Novel and Potent Agents for the Treatment of Glioblastoma. J. Med. Chem.2025, 68, 247鈭�260.
2. Shiqi Hu#, Yuhang Fan#, Yumo Zhao, Zhengyang Gao, Jie Lu, Jian Li, Jinlian Wei*, Yongqiang Zhang*. Design, synthesis and anti-GBM activities of amide-modified Curcumol derivatives. Bioorg. Med. Chem. Lett. 2025, 130265, 125鈥�126.
3. Yumo Zhao; Yi Wan, Qiyang Yuan, Jinlian Wei*, Yongqiang Zhang*. Photocatalytic C鈭扴i Bond Formations Using Pentacoordinate Silylsilicates as Silyl Radical Precursors: Synthetic Tricks Using Old Reagents, Org. Lett.2023, 25: 1386-1391.
4. Jiajie Zhu , Yi Wan , Qiyang Yuan , Jinlian Wei *, Yongqiang Zhang *. Research of Visible Light/Lewis Base Dual Catalytic Defluorinative Silylation of Trifluoromethyl-Substituted Alkenes. Chin. J. Org. Chem.2023, 43, 3623-3634.
5. JinlianWei#, Yongyun Li#, Ruoxi Li, Xin Chen, Tiannuo Yang, Liang Liao, Yuqing Xie, Jin Zhu, Fei Mao, Renbing Jia*, Xiaofang Xu*, Jian Li*. Drug Repurposing of Propafenone to Discover Novel Anti-tumor Agents by Impairing Homologous Recombination to Delay DNA Damage Recovery of Rare Disease Conjunctival Melanoma. Eur. J. Med. Chem. 2023, 250, 115238.
6. Jinlian Wei#, Xin Chen#, Yongyun Li#, Ruoxi Li, Keting Bao, Liang Liao, Yuqing Xie, Tiannuo Yang, Jin Zhu, Fei Mao, Shuaishuai Ni, Renbing Jia*, Xiaofang Xu*, Jian Li*. Cucurbitacin B-induced G2/M cell cycle arrest of conjunctival melanoma cells mediated by GRP78-FOXM1-KIF20A pathway. Acta Pharm. Sin. B. 2022, 12(10):3861-3876.
7. Keting Bao#, Yongyun Li#, Jinlian Wei#, Ruoxi Li, Jie Yang, Jiahao Shi, Baoli Li, Jin Zhu, Fei Mao*, Renbing Jia*, Jian Li*. Fangchinoline suppresses conjunctival melanoma by directly binding FUBP2 and inhibiting the homologous recombination pathway. Cell Death Dis.2021, 12 (4), 380.
8. Xin Chen#, Xi Yang#, Fei Mao#, Jinlian Wei#, Yixiang Xu, Baoli Li, Jin Zhu, Shuaishuai Ni*, Lijun Jia*, Jian Li*. Development of novel benzimidazole-derived neddylation inhibitors for suppressing tumor growth invitro and in vivo. Eur. J. Med. Chem. 2021, 210, 112964.
9. Jinlian Wei, Yingrui Yang, Mengchen Lu, Yonghua Lei, Lili Xu, Zhengyu Jiang, Xiaoli Xu, Xiaoke Guo, Xiaojin Zhang, Haopeng Sun*, Qidong You, Recent Advances in the Discovery of HIF-1alpha-p300/CBP Inhibitors as Anti-Cancer Agents. Mini-Rev. Med. Chem. 2018,18 (4), 296-309.
10. Jinlian Wei, Yingrui Yang, Yali Li, Xiaofei Mo, Xiaoke Guo, Xiaojin Zhang, Xiaoli Xu, Zhengyu Jiang, Qidong You*, Synthesis and evaluation of N-(benzofuran-5-yl)aromaticsulfonamide derivatives as novel HIF-1 inhibitors that possess anti-angiogenic potential, Bioorg.Med. Chem.2017, 25 (6): 1737-1746.
11. Xiaoli Xu, Yingrui Yang, Xiaofei Mo, Jinlian Wei, Xiaojin Zhang, Qidong You*, Design, synthesis, and evaluation of benzofuran derivatives as novel anti-pancreatic carcinoma agents via in terfering the hypoxia environment by targeting HIF-1alpha pathway, Eur. J. Med. Chem.2017, 137: 45-62.
12. Jinlian Wei, Yingrui Yang, Mengchen Lu, Lili Xu, Fang Liu, Zhenwei Yuan, Qichao Bao, Zhengyu Jiang, Xiaoli Xu, Xiaoke Guo, Xiaojin Zhang, Qidong You*, Haopeng Sun*, Escape, or Vanish: Control the Fate of p53 through MDM2-Mediated Ubiquitination. Anticancer Agents Med. Chem.2015, 16 (2): 174-189.
13. Yingrui Yang, Jinlian Wei, Xiaofei Mo, Zhenwei Yuan, Jialing Wang, Chao Zhang, Yieyue Xie, Qidong You*, Haopeng Sun*, Discovery and optimization of new benzofuran derivatives against p53-independent malignant cancer cells through inhibition of HIF-1 pathway. Bioorg Med Chem Lett.2016, 26 (11): 2713-2718.
14. Xin Xue, Jinlian Wei, Lili Xu, Meiyang Xi, Xiaoli Xu, Fang Liu, Xiaoke Guo, Lei Wang, Xiaojin Zhang, Mingye Zhang, Mengchen Lu, Haopeng Sun*, Qidong You*, Effective screening strategy using ensembled pharmacophore models combined with cascade docking: application to p53-MDM2 interaction inhibitors. J Chem Inf Model. 2013, 53 (10): 2715-2729.